The economic burden to the public health system of treating non-viral injecting-related injury and disease in Australia (a cost of illness analysis)

Sweeney, Rohan, Conroy, Andrew B., Dwyer, Robyn and Aitken, Campbell K. (2009) The economic burden to the public health system of treating non-viral injecting-related injury and disease in Australia (a cost of illness analysis). Australian and New Zealand Journal of Public Health, 33 4: 352-357. doi:10.1111/j.1753-6405.2009.00407.x


Author Sweeney, Rohan
Conroy, Andrew B.
Dwyer, Robyn
Aitken, Campbell K.
Title The economic burden to the public health system of treating non-viral injecting-related injury and disease in Australia (a cost of illness analysis)
Journal name Australian and New Zealand Journal of Public Health   Check publisher's open access policy
ISSN 1326-0200
1753-6405
Publication date 2009-08-01
Sub-type Article (original research)
DOI 10.1111/j.1753-6405.2009.00407.x
Open Access Status
Volume 33
Issue 4
Start page 352
End page 357
Total pages 6
Place of publication Richmond, Vic., Australia
Publisher Wiley-Blackwell Publishing Asia
Language eng
Formatted abstract
Objective: We estimated the cost to the public health system of treating Injecting-Related Injuries and Diseases (IRIDs) in the three most populous states in Australia in the 12 months over 2005/06.
Methods: We conducted a cost of illness analysis from the perspective of the public health system. Costs of treating IRIDs in the community were estimated from health service utilisation surveys of injecting drug users and physicians (yielding data on Government subsidised physician visits, medicines prescribed and emergency department presentations). Data on admitted hospitalisations in public hospitals due to IRIDs were extracted from State Government databases. Appropriate costs were attached to all Government-borne services and prescriptions to estimate the total cost to the public health system of treating IRIDs in 2005/06 in Queensland, NSW and Victoria.
Results: Our estimate of the cost to the public health system of treating IRIDs in Queensland, NSW and Victoria in 2005/06 was $20 million.
Conclusion: IRIDs are an under-recognised harm resulting from injecting drug use, but the economic burden of IRIDs in Australia are non-negligible. Research is needed to identify cost effective programs to reduce the clinical and economic burden caused by IRIDs, particularly to reduce hospitalisations due to IRIDs.
Implications: General practitioners, clinicians and other health workers need to be alert to IRIDs in their injecting drug user clients to prevent progression to more serious disease and consequent elevation of the associated economic costs.
Keyword Economic burden
Cost of illness
Injecting drug use
Injecting-related injury and disease
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Public Health Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 6 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 6 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Thu, 03 Sep 2009, 17:44:45 EST by Mr Andrew Martlew on behalf of School of Public Health